Revenue exceeded expectations! "The first stock of large medical models," iFlytek Medical (02506), grew 49.4% in the first half of the year, with a clear strategic focus across its three major segments.

On August 18, iFlytek Medical (02506) released its mid-term results for 2026. In the first half of the year, the company's operating income reached 446 million yuan, a year-on-year increase of 49.4%, exceeding market expectations. The profit performance was impressive, with a gross profit of 236 million yuan, up 53.5% year-on-year, and the overall gross margin rising to 52.9%, an increase of 1.4 percentage points compared to the same period last year, indicating a continuous optimization of the profit structure. In terms of business structure, the strategic focus on the three major segments is clear. The AI Diagnostic Assistant contributed an income of 202 million yuan, a year-on-year increase of 47.5%, accounting for 45.2% of total revenue, continuing to stabilize its foundational role; the AI Health Assistant achieved revenue of 182 million yuan, a substantial increase of 74.9% year-on-year, raising its share to 40.9%, becoming the fastest-growing core engine; the AI Digital Foundation generated an income of 62 million yuan, a year-on-year increase of 7.9%, accounting for 13.9%, steadily expanding. As of the end of June this year, the companys products covered 828 districts and counties across 31 provinces in the country, over 77,000 grassroots medical institutions, and 727 graded hospitals, laying a solid foundation for future growth through scaled deployment.